During such conditions combination therapy of FTY720 combined with procedures that negate proinflammatory cytokines such as IL-6 may emerge as a broadly applicable approach to treat wider range of inflammatory and autoimmune diseases. The gene discussed is IL6; the disease is autoimmune disease.